Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company pr...
Q2 2026
Aug 13, 2026
Q1 2026
May 13, 2026
FY 2025
Mar 18, 2026
Q4 2025
Q3 2025
Nov 13, 2025